On Tuesday, Exagen Inc (NASDAQ: XGN) opened lower -4.68% from the last session, before settling in for the closing price of $6.63. Price fluctuations for XGN have ranged from $2.67 to $12.23 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 19.20% over the past five years. Company’s average yearly earnings per share was noted -5.86% at the time writing. With a float of $15.32 million, this company’s outstanding shares have now reached $22.51 million.
Let’s look at the performance matrix of the company that is accounted for 209 employees.
Exagen Inc (XGN) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Exagen Inc is 32.38%, while institutional ownership is 43.88%. The most recent insider transaction that took place on Oct 16 ’25, was worth 375,598. In this transaction President and CEO of this company sold 31,787 shares at a rate of $11.82, taking the stock ownership to the 714,427 shares. Before that another transaction happened on Sep 02 ’25, when Company’s Chief Financial Officer sold 20,466 for $9.79, making the entire transaction worth $200,362. This insider now owns 269,026 shares in total.
Exagen Inc (XGN) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -5.86% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 35.62% during the next five years compared to 19.20% growth over the previous five years of trading.
Exagen Inc (NASDAQ: XGN) Trading Performance Indicators
Check out the current performance indicators for Exagen Inc (XGN). In the past quarter, the stock posted a quick ratio of 3.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.93, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of Exagen Inc (XGN)
Exagen Inc (NASDAQ: XGN) saw its 5-day average volume 0.33 million, a positive change from its year-to-date volume of 0.25 million. As of the previous 9 days, the stock’s Stochastic %D was 18.71%.
During the past 100 days, Exagen Inc’s (XGN) raw stochastic average was set at 2.15%, which indicates a significant decrease from 9.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.36 in the past 14 days, which was lower than the 0.42 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.07, while its 200-day Moving Average is $7.76. Nevertheless, the first resistance level for the watch stands at $6.56 in the near term. At $6.81, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.99. If the price goes on to break the first support level at $6.13, it is likely to go to the next support level at $5.95. The third support level lies at $5.70 if the price breaches the second support level.
Exagen Inc (NASDAQ: XGN) Key Stats
There are currently 22,663K shares outstanding in the company with a market cap of 143.23 million. Presently, the company’s annual sales total 55,640 K according to its annual income of -15,120 K. Last quarter, the company’s sales amounted to 17,240 K and its income totaled -7,090 K.
